Cargando…
iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
The discovery of human pluripotent stem cells (PSCs) at the turn of the century opened the door to a new generation of regenerative medicine research. Among PSCs, the donors available for induced pluripotent stem cells (iPSCs) are greatest, providing a potentially universal cell source for all types...
Autores principales: | Karagiannis, Peter, Kim, Shin-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424143/ https://www.ncbi.nlm.nih.gov/pubmed/34373366 http://dx.doi.org/10.14348/molcells.2021.0078 |
Ejemplares similares
-
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
por: Goldenson, Benjamin H., et al.
Publicado: (2022) -
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
por: Dame, Keri, et al.
Publicado: (2020) -
An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
por: Hsu, Li-Jie, et al.
Publicado: (2021) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023) -
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
por: Suzuki, Daisuke, et al.
Publicado: (2019)